Holen Sie sich die Stockscreener-App
2.66
1.14%
0.03
Schlusskurs vom Vortag:
$2.63
Offen:
$2.66
24-Stunden-Volumen:
97,300
Relative Volume:
0.06
Marktkapitalisierung:
$19.84M
Einnahmen:
$34.75M
Nettoeinkommen (Verlust:
$-24.76M
KGV:
-0.2217
EPS:
-12
Netto-Cashflow:
$-50.91M
1W Leistung:
-4.66%
1M Leistung:
+11.76%
6M Leistung:
-72.00%
1J Leistung:
-92.95%
1-Tages-Spanne:
$2.53
$2.75
1-Wochen-Bereich:
$2.35
$3.09
52-Wochen-Spanne:
$2.15
$88.75
Allurion Technologies Inc Stock (ALUR) Company Profile
Firmenname
Allurion Technologies Inc
Sektor
Branche
Telefon
508-647-4000
Adresse
11 HURON DR STE 200, NATICK
Vergleichen Sie ALUR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
2.66 | 20.81M | 34.75M | -24.76M | -50.91M | -12.00 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-14 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2024-10-02 | Eingeleitet | TD Cowen | Buy |
| 2024-09-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-02-09 | Eingeleitet | Jefferies | Buy |
Allurion Technologies Inc Aktie (ALUR) Neueste Nachrichten
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks - The Globe and Mail
Allurion to Present at Jefferies Global Healthcare Conference - BioSpace
When the Price of (ALUR) Talks, People Listen - news.stocktradersdaily.com
ALURALLURION TECHNOLOGIES INC Latest Stock News & Market Updates - Stock Titan
Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results - MSN
Allurion Presents Data on Increasing Muscle Mass and Decreasing Fat Mass in Patients Treated With the Allurion Program - BioSpace
Allurion Weight Loss Program Builds Muscle Mass 6.6%, Cuts Fat 11% in Clinical Study | ALUR Stock News - Stock Titan
Zacks Industry Outlook Highlights Insulet, MacroGenics, Cellectar Biosciences and Allurion Technologies - Yahoo Finance
4 Medical Product Stocks to Watch From a Challenging Industry - Yahoo Finance
Trend Tracker for (ALUR) - news.stocktradersdaily.com
Research Analysts Offer Predictions for ALUR FY2025 Earnings - Defense World
Yale University's Strategic Exit from Allurion Technologies Inc: A 13F Filing Insight - GuruFocus
Allurion Technologies Earnings Call: Transition and Growth - TipRanks
Allurion outlines path to FDA submission and expects revenue ramp as B2B2C strategy expands in 2025 - MSN
Allurion Technologies, Inc. (ALUR) Q1 Earnings Beat Estimates - MSN
Allurion Technologies Inc (ALUR) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Allurion Technologies Reports Q1 2025 Financial Results - TipRanks
Allurion Technologies (ALUR) Unveils Promising Obesity Treatment Results | ALUR Stock News - GuruFocus
Allurion Technologies (ALUR) Q1 2025 Results Highlight Revenue a - GuruFocus
Transcript : Allurion Technologies Inc., Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com
What To Expect From Allurion Technologies Inc (ALUR) Q1 2025 Ear - GuruFocus
Allurion To File Final Module Of Weight Loss Balloon To FDA For Approval Next Month - Nasdaq
Allurion Technologies (ALUR) Surges Over 50% Following Data Pres - GuruFocus
Earnings call transcript: Allurion Technologies Q1 2025 sees revenue drop, stock surges - Investing.com
Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript - MSN
ALUR Reports Q1 Revenue Exceeding Expectations, Anticipates Prom - GuruFocus
Allurion Technologies Q1 2025 Financial Results - TradingView
ALUR Reports Q1 Revenue Exceeding Expectations, Anticipates Promising Year | ALUR Stock News - GuruFocus
Allurion Technologies reports Q1 EPS 20c vs. ($2.78) last year - TipRanks
Allurion Reports First Quarter 2025 Financial Results and Provides Business Update - marketscreener.com
After-Market Rally For Allurion (ALUR) As New Data Sparks Investor Optimism - Stocks Telegraph
Allurion Presents Data on the Allurion Balloon and AI-Powered Virtual Care Suite with and without GLP-1s to Optimize Muscle Mass and Increase Weight Loss - 01net
Allurion reports weight loss breakthrough at obesity congress - Investing.com Australia
Allurion reports weight loss breakthrough at obesity congress By Investing.com - Investing.com Nigeria
New Clinical Data: Allurion's Swallowable Balloon Supercharges GLP-1 Weight Loss Results, Preserves Muscle - Stock Titan
What To Expect From Allurion Technologies Inc (ALUR) Q1 2025 Earnings - Yahoo Finance
Allurion Technologies (ALUR) Projected to Post Quarterly Earnings on Wednesday - Defense World
Allurion to Report First Quarter 2025 Financial Results on May 14, 2025 - marketscreener.com
Obesity Tech Leader Allurion Sets Q1 2025 Earnings Release Date: Key Updates Expected - Stock Titan
Geode Capital Management LLC Has $213,000 Holdings in Allurion Technologies Inc. (NYSE:ALUR) - Defense World
Allurion Technologies Inc. (NYSE:ALUR) Sees Large Drop in Short Interest - Defense World
Allurion Technologies, Inc. (ALUR) Reports Q4 Loss, Lags Revenue Estimates - MSN
Finanzdaten der Allurion Technologies Inc-Aktie (ALUR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.36%
1.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):